Milestone Pharmaceuticals : Corporate Presentation -March 28, 2024 at 08:38 am EDT
Company Overview March 28, 2024 Forward Looking Statement The Presentation contains forward-looking statements within...
Source: marketscreener.com
Rapid Ventricular News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rapid Ventricular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rapid Ventricular Today - Breaking & Trending Today
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate compared to...
Source: marketscreener.com
Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American Heart Association Scientific Sessions 2023
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2...
Source: prnewswire.com
Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update
NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener
Source: marketscreener.com
Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
Source: prnewswire.com